Plasma glucagon increased within the first hour following ZT-01 treatment compared to controls, and remained elevated until 1 h after insulin bolus administration for hypoglycemia induction (2 h after ZT-01 dosing) (Figure 5E). This evidence concerns the gene INS and Hypoglycemia.